Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02116608
Other study ID # 13-2819
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date September 2014
Est. completion date September 5, 2019

Study information

Verified date August 2021
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study plans to learn more about the different ways used to treat tracheostomy granulomas. Investigators want to see which standard of care method (steroid application, silver nitrate, or betadine) is more successful in treating tracheostomy granulomas.


Description:

Upon joining the study patients will be assigned to one of the three treatment groups (steroid application, silver nitrate, and betadine). These three treatments are standard of care and patients would have been treated with one of them anyway. Patients will be followed for an observation period of six weeks with follow-up appointments, per standard of care, every two weeks (+/- 3 days) in order for a physician to evaluate if the treatment method is working. If during a follow-up visit, the physician determines the treatment method is not working, the follow-up period will end and participation in the study will be complete. In addition, if a patient is given a different form of treatment during the observation period, such as in the emergency department or through their primary care physician, the follow-up period will end and participation in the study will be complete.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date September 5, 2019
Est. primary completion date September 5, 2019
Accepts healthy volunteers No
Gender All
Age group 31 Days to 17 Years
Eligibility Inclusion Criteria: - Children's Hospital Colorado inpatient or outpatient - 31 days to 17 years (inclusive) - Needs treatment for a tracheostomy granuloma Exclusion Criteria: - Tracheostomy granuloma has been treated in the last two weeks

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Betadine
Apply locally as needed.
Silver Nitrate
Arzol Silver Nitrate Applicators may be applied directly to mucous membranes and other moist surfaces. In the case of dry skin, the applicator tip should be dipped in water immediately before use. Apply carefully to the area to be treated.
Hydrocortisone Butyrate Cream, 1.0%
Hydrocortisone butyrate cream, 1.0% should be applied to the affected area as a thin film two or three times daily depending on the severity of the condition.

Locations

Country Name City State
United States Children's Hospital Colorado Aurora Colorado

Sponsors (1)

Lead Sponsor Collaborator
University of Colorado, Denver

Country where clinical trial is conducted

United States, 

References & Publications (4)

Al-Samri M, Mitchell I, Drummond DS, Bjornson C. Tracheostomy in children: a population-based experience over 17 years. Pediatr Pulmonol. 2010 May;45(5):487-93. doi: 10.1002/ppul.21206. — View Citation

Chen C, Bent JP, Parikh SR. Powered debridement of suprastomal granulation tissue to facilitate pediatric tracheotomy decannulation. Int J Pediatr Otorhinolaryngol. 2011 Dec;75(12):1558-61. doi: 10.1016/j.ijporl.2011.09.007. Epub 2011 Oct 11. — View Citation

McShane DB, Bellet JS. Treatment of hypergranulation tissue with high potency topical corticosteroids in children. Pediatr Dermatol. 2012 Sep-Oct;29(5):675-8. doi: 10.1111/j.1525-1470.2012.01724.x. Epub 2012 May 21. — View Citation

Yaremchuk K. Regular tracheostomy tube changes to prevent formation of granulation tissue. Laryngoscope. 2003 Jan;113(1):1-10. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Success and Failure Rates for Each Treatment Method Definition of success: The investigators are defining successful treatment of tracheostomy granulomas as a decrease in the frequency of granulomas over a six week observation period using the assigned treatment or partial or complete resolution of the granuloma. Partial resolution is defined as 25-75% resolution and complete resolution is defined as greater than 75% resolution.
Definition of failure: The investigators are defining a treatment as a failure if during the six week observation period of using the assigned treatment, there is either no improvement in the resolution or there has been an increase in size or frequency of tracheostomy granulomas.
Over 6 weeks
Primary Categorical Improvement (Degree of Improvement) Categorical success/failure data. the size of the granuloma will be measured and recorded. The percent circumference will also be measured. The approximate percent decrease in the granuloma size will be determined to determine the category subject's change in granuloma:
i. Complete resolution: >90% improvement (Score = 4) ii. Improvement: 50 - 90% improvement (Score = 3) iii. Minimal improvement: < 50% improvement (Score = 2) iv. No improvement (Score = 1) v. Worsening (Score = 0)
Over 6 Weeks
Secondary Length of Time Between Administration of the Treatment and the Determination of Treatment Failure, if Applicable Over the 6 week treatment period, the time from administration of the treatment to the time of treatment failure, if it occurs, will be evaluated and documented. Over 6 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06375369 - Digital Health Pathway for Children With Medical Complexity Requiring Tracheostomy N/A
Completed NCT01976819 - Clinical Assessment of New Speaking Valve With Heat and Moisture Exchanger (HME) for Tracheotomized Patients N/A
Terminated NCT00323986 - Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy Phase 2
Not yet recruiting NCT06236542 - Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety N/A
Completed NCT03955874 - Mechanical Ventilation Discontinuation Practices
Completed NCT04668742 - Efficacy and Safety of the DYNAtraq Device to Prevent Complications in Tracheostomy in Mechanically Ventilated Patients N/A
Recruiting NCT05047432 - Concordance of Methods to Select Tracheostomy Tube Size for Adults in Intensive Care
Recruiting NCT06120790 - Investigation of a 3 oz Water Protocol on Patients With Tracheostomies
Withdrawn NCT05658029 - An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a Tracheostomy Phase 1
Active, not recruiting NCT05041894 - Effect of Body Tilting on Diaphragm Excursion and Thickness in the Stroke Patients With Tracheotomy by Ultrasonography
Active, not recruiting NCT02990871 - Efficacy of an Early Rehabilitation on Decannulation Time of Patients With Severe Acquired Brain Injury N/A
Enrolling by invitation NCT06283953 - Boosting Resources for Tracheostomy Care at Home N/A
Not yet recruiting NCT04872881 - Comparison of Effectiveness of Different Airway Management Methods During Percutaneous Tracheostomy Phase 4
Completed NCT02512744 - Reducing Decannulation Time: Limitation of Decannulation Capping Trials (REDECAP) N/A
Recruiting NCT04642703 - Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy
Completed NCT04447638 - Percutaneous Tracheostomy With COVID-19
Completed NCT05434442 - Caregivers Tracheal Aspiration Training N/A
Not yet recruiting NCT06431048 - No DIET Trial: Dogmatic Interruption of Enteral nuTrition N/A
Recruiting NCT02469909 - Comparison Between Immediate and Gradual Decannulation N/A
Completed NCT03512054 - Pilot Study Evaluating the Success (= Safe Decannulation) of a Standardized Tracheotomy Weaning Procedure in Brain-injury's Patients N/A